Urist Marshall reported grant involving 5,341 shares of Royalty Pharma plc at $0.00 for $0 on Nov 4, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
EVP, Research & Investments
EVP, Research & Investments
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
5,341Class A Ordinary Shares
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
5,341Direct
Trade date
Nov 4, 2026Grant
Filed
Nov 6, 2026, 4:17 PM ET2-day reporting delay
Accession
0001838139-26-000030Code A · Transaction 394786
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

RPRX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RPRX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −16%1w ago −3.7%1d ago −1.3%
Returns since7d +3%30d90d180d1y

Footnotes in full

F1: Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards. F2: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("RPH"). Each Class B Interest in RPH so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Amended and Restated Exchange Agreement. No additional value will be paid by the Reporting Person in connection with the exchange. F3: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in RPH at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in RPH issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.